ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991

OSI Underestimated Magnitude Of Gallo Case: Hadley

February 3, 1995

Vanderbilt Lung Cancer Trial For Never Smokers Online

September 25, 2009

Colorado Center Delays New Core Grant Application

July 13, 1979

Agriculture Dept. Asks clearinghouse To Consider Broader Risk Assessment Data

July 14, 1978

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984